| 摘要 |
The invention relates to a pharmaceutical composition for treating inflammatory and autoimmune diseases, the composition comprising: (a) a compound neutralizing granulocyte-macrophage colony stimulating factor (GM-CSF); and (b) a compound neutralizing interleukin-17 (IL-17), wherein the compound neutralizing GM-CSF is an antibody or a functional fragment thereof binding to GM-CSF, and wherein the compound neutralizing IL-17 is and antibody or a functional fragment thereof binding to IL-17. |
